Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vagus nerve stimulation for refractory epilepsy.

P Boon1, K Vonck, J De Reuck

  • 1Reference Centre for Refractory Epilepsy, Department of Neurology, Ghent University Hospital, Belgium.

Seizure
|November 10, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unlocking seizure freedom: A European Delphi panel study on the clinical, humanistic, and economic value of seizure control in epilepsy.

Seizure·2026
Same author

Defining seizure freedom in epilepsy: a pragmatic literature review.

Seizure·2026
Same author

Severe autonomic nervous system imbalance in Lennox-Gastaut syndrome patients demonstrated by heart rate variability recordings.

Epilepsy research·2021
Same author

Dysphagia, dysarthria and aphasia following a first acute ischaemic stroke: incidence and associated factors.

European journal of neurology·2020
Same author

Neurological manifestations and neuro-invasive mechanisms of the severe acute respiratory syndrome coronavirus type 2.

European journal of neurology·2020
Same author

Neurophysiological investigations of drug resistant epilepsy patients treated with vagus nerve stimulation to differentiate responders from non-responders.

European journal of neurology·2020
Same journal

Effect of chronic migraine treatment on functional seizure frequency: An exploratory study.

Seizure·2026
Same journal

Development of a standard for epilepsy semiology and semiological description dataset: a modified Delphi study.

Seizure·2026
Same journal

UNC13A-related neurodevelopmental disorders in children: epilepsy phenotypes and antiseizure medication response.

Seizure·2026
Same journal

Switching from oxcarbazepine to eslicarbazepine in patients with focal epilepsy: A systematic review and single-arm meta-analysis.

Seizure·2026
Same journal

Efficacy, tolerability, and EEG lateralization-based predictors of neuropsychiatric adverse events in pediatric SeLECTS treated with perampanel monotherapy.

Seizure·2026
Same journal

Cross-cultural validation of the International Classification of Cognitive Disorders in Epilepsy (IC-CoDE) in Chinese-speaking people with epilepsy.

Seizure·2026
See all related articles

Vagus nerve stimulation (VNS) offers a safe and effective treatment for refractory epilepsy, reducing seizure frequency in many patients over time. While not a cure, VNS provides significant benefits for adults and children, with ongoing research into its mechanisms.

Area of Science:

  • Neuroscience
  • Neurology
  • Medical Technology

Background:

  • Vagus nerve stimulation (VNS) is an established neurophysiological therapy for drug-resistant epilepsy.
  • Over 10,000 patients have received VNS implants since 1989.
  • Efficacy and safety have been demonstrated in randomized controlled trials.

Purpose of the Study:

  • To review the efficacy, safety, and mechanism of action of VNS in epilepsy treatment.
  • To assess long-term outcomes and potential applications of VNS.
  • To highlight advancements in understanding VNS's neurophysiological effects.

Main Methods:

  • Review of randomized controlled studies and long-term patient data.
  • Analysis of neurophysiological, neuroanatomical, and neurochemical research.

Related Experiment Videos

  • Evaluation of cerebral blood flow studies in VNS-treated patients and animals.

    • Main Results:

    • VNS significantly reduces seizure frequency, with efficacy increasing over time.
    • Approximately one-third of patients experience >50% seizure reduction; another third experience 30-50% reduction.
    • Common side effects include voice alteration and coughing; VNS is generally safe and cost-effective long-term.

    Conclusions:

    • VNS is an efficacious and safe adjunctive therapy for refractory epilepsy in diverse age groups.
    • Further research into VNS mechanisms could enhance clinical efficacy and epilepsy understanding.
    • VNS shows potential as a treatment for other conditions like depression and pain.